Elizabeth A. Platz | |
---|---|
Academic background | |
Education | MPH, 1989, Yale School of Public Health ScD, 1995, Harvard T.H. Chan School of Public Health |
Thesis | Cancer risk associated with chronic internal exposure to alpha-particles from Thorotrast (1995) |
Academic work | |
Institutions | Johns Hopkins University |
Doctoral students | Hannah P. Yang |
Elizabeth A. Platz is an American cancer epidemiologist. As a professor at Johns Hopkins University,Platz was appointed editor-in-chief of the journal Cancer Epidemiology,Biomarkers &Prevention and elected a Fellow of the American Association for the Advancement of Science.
Platz completed her Master's degree in public health from Yale School of Public Health and her Doctor of Science from the Harvard T.H. Chan School of Public Health. [1]
Following her ScD,Platz joined the faculty at Johns Hopkins University as an assistant professor in the Department of Epidemiology in 1999. [2] While serving in this role,she started the Hormones in Umbilical Cord Blood Study (HUB) to evaluate whether umbilical cord blood hormone and growth factor concentrations differ by race. [3] Platz also co-led a 10-year study of more than 30,000 health professionals that found the longer men take cholesterol-lowering drugs,the far less likely they were to develop advanced prostate cancer. [4] In 2008,Platz was appointed co-director of the Cancer Prevention and Control Program at the Sidney Kimmel Comprehensive Cancer Center. [5]
In 2010,Platz was promoted to the rank of full professor [6] and was selected as the inaugural Abeloff Scholar to support her study into the causes and risk factors of cancer. [7] In 2019,Platz was appointed editor-in-chief of the journal Cancer Epidemiology,Biomarkers &Prevention, one of eight journals published by the American Association for Cancer Research. [8] She was also elected a Fellow of the American Association for the Advancement of Science. [5]
Prostate cancer is the uncontrolled growth of cells in the prostate,a gland in the male reproductive system below the bladder. Early prostate cancer causes no symptoms. Abnormal growth of prostate tissue is usually detected through screening tests,typically blood tests that check for prostate-specific antigen (PSA) levels. Those with high levels of PSA in their blood are at increased risk for developing prostate cancer. Diagnosis requires a biopsy of the prostate. If cancer is present,the pathologist assigns a Gleason score,and a higher score represents a more dangerous tumor. Medical imaging is performed to look for cancer that has spread outside the prostate. Based on the Gleason score,PSA levels,and imaging results,a cancer case is assigned a stage 1 to 4. Higher stage signifies a more advanced,more dangerous disease.
Alcohol causes cancers of the oesophagus,liver,breast,colon,oral cavity,rectum,pharynx,and larynx,and probably causes cancers of the pancreas. Consumption of alcohol in any quantity can cause cancer. The more alcohol is consumed,the higher the cancer risk,and no amount can be considered safe. Alcoholic beverages were classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) in 1988. An estimated 3.6% of all cancer cases and 3.5% of cancer deaths worldwide are attributable to consumption of alcohol. 740,000 cases of cancer in 2020 or 4.1% of new cancer cases were attributed to alcohol.
Joseph W. Cullen was an American cancer prevention and rehabilitation researcher and briefly director of the AMC Cancer Research Center (1989-1990). He previously worked at the VA Hospital in Maryland (1968-1973),the National Institutes of Health (1973),the National Cancer Institute (NCI),and the Jonsson Comprehensive Cancer Center (1976-1982),holding high-level positions such as division director at several. He was a coordinator,creator,and researcher for the Smoking Tobacco and Cancer Program at the NCI,the largest anti-smoking campaign in the world at that time. Cullen wrote more than 90 publications in his lifetime,including four books.
JoAnn Elisabeth Manson is an American physician and professor known for her pioneering research,public leadership,and advocacy in the fields of epidemiology and women's health.
David A. Savitz is a professor of Community Health in the Epidemiology Section of the Program in Public Health,Vice President for Research,and Professor of Obstetrics and Gynecology,at The Alpert Medical School of Brown University,and Associate Director for Perinatal Research in The Department of Obstetrics and Gynecology at Women &Infants Hospital,both in Providence,Rhode Island. Savitz is the author of Interpreting epidemiologic evidence:strategies for study design and analysis (ISBN 0-19-510840-X) and more than 275 peer-reviewed articles. He was elected to the Institute of Medicine in 2007.
George Wills Comstock was a public health physician,epidemiologist,and educator. He was known for significant contributions to public health,specifically in the fields of micronutrient deficiencies,tuberculosis,and cardiovascular disease. He served as the editor-in-chief for the American Journal of Epidemiology.
Judith Ann Clements is an Australian academic and educator,specializing in Kallikrein proteases in prostate and ovarian cancers. Clements is the scientific director at the Australian Prostate Cancer Research Centre –Queensland and was head of the Cancer Research Program at the Institute of Health and Biomedical Innovation (IHBI) of Queensland University of Technology at the Translational Research Institute (Australia) from 1997–2014.
Eugenia E. “Jeanne”Calle (1952–2009) was an American cancer epidemiologist.
David John Hunter is an Australian epidemiologist and the Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health. He was previously a professor in Harvard University's departments of Epidemiology and Nutrition. Hunter was associate epidemiologist,Channing Laboratory,Brigham and Women's Hospital,where he was involved with the programs in breast cancer,cancer epidemiology,and cancer genetics research teams. At Oxford he directs the Translational Epidemiology Unit and leads a collaborative project between Oxford and the Harvard T.H. Chan School of Public Health.
Elizabeth Terrell Hobgood "Terry" Fontham is an American cancer epidemiologist,public health researcher,and founding dean of the Louisiana State University Health Sciences Center New Orleans School of Public Health.
Haroutune Armenian,is a Lebanese born Armenian-American academic,physician,doctor of public health (1974),Professor,President of the American University of Armenia,President Emeritus,American University of Armenia. Professor in Residence,UCLA,Fielding School of Public Health.
Curtis. C. Harris is the head of the Molecular Genetics and Carcinogenesis Section and chief of the Laboratory of Human Carcinogenesis at the Center for Cancer Research of the National Cancer Institute,NIH.
High-dose estrogen therapy (HDE) is a type of hormone therapy in which high doses of estrogens are given. When given in combination with a high dose of progestogen,it has been referred to as pseudopregnancy. It is called this because the estrogen and progestogen levels achieved are in the range of the very high levels of these hormones that occur during pregnancy. HDE and pseudopregnancy have been used in medicine for a number of hormone-dependent indications,such as breast cancer,prostate cancer,and endometriosis,among others. Both natural or bioidentical estrogens and synthetic estrogens have been used and both oral and parenteral routes may be used.
Cheryl Ann Marie Anderson is an American epidemiologist. Anderson is a professor at and founding Dean of the University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science. Anderson's research focus is on nutrition and chronic disease prevention in under-served human populations.
Rebecca D. Jackson was a medical researcher,medical practitioner and professor of endocrinology,diabetes and metabolism. Her research was significant in the understanding and treatment of osteoporosis. She also researches the opioid crisis in Ohio.
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma,and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China,Hong Kong,and Malaysia.
Josef Coresh is an American epidemiologist. He is the inaugural George W. Comstock Professor in the Department of Epidemiology at Johns Hopkins University. Coresh serves as the director of both the Cardiovascular Epidemiology Training Program and the George W. Comstock Center for Public Health Research and Prevention at the Johns Hopkins School of Medicine.
Rachael Zoe Stolzenberg-Solomon is an American epidemiologist and dietitian. She is a senior investigator and head of the metabolic epidemiology branch at the National Cancer Institute.
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute.
Susan Hankinson is an American cancer researcher who is the Distinguished Professor of Epidemiology at the University of Massachusetts Amherst. Her research considers cancer epidemiology and the etiology of breast cancer. Her work has demonstrated the relationship between hormones and breast cancer risk. In 2023,she was awarded the American Association for Cancer Research Award for Research Excellence in Cancer Epidemiology and Prevention.